Last reviewed · How we verify
Carampicillin (BACAMPICILLIN)
At a glance
| Generic name | BACAMPICILLIN |
|---|---|
| Drug class | bacampicillin |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| First approval | 1980 |
Approved indications
- Gonorrhea
- Haemophilus influenzae pneumonia
- Infection of skin AND/OR subcutaneous tissue
- Infective otitis media
- Pharyngitis
- Sinusitis
- Urinary tract infectious disease
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Carampicillin CI brief — competitive landscape report
- Carampicillin updates RSS · CI watch RSS